BDBM62552 3-Methyl-7-(4-methyl-benzyl)-8-(pyrimidin-2-ylsulfanyl)-3,7-dihydro-purine-2,6-dione::3-methyl-7-(4-methylbenzyl)-8-(2-pyrimidylthio)xanthine::3-methyl-7-[(4-methylphenyl)methyl]-8-(2-pyrimidinylthio)purine-2,6-dione::3-methyl-7-[(4-methylphenyl)methyl]-8-pyrimidin-2-ylsulfanyl-purine-2,6-dione::3-methyl-7-[(4-methylphenyl)methyl]-8-pyrimidin-2-ylsulfanylpurine-2,6-dione::MLS000075979::SMR000014467::cid_651265

SMILES O=C(c1cnc2c(c1)CCCN2c1ccn2c(=O)n(CC3COC3)nc2c1)N1CCCCC1

InChI Key InChIKey=XAQONNDZOSKFRZ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62552   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62552BDBM62552(US12577217, Example 1-58)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent